1.Liu, Y.; Yin, L., alpha-Amino acid N-carboxyanhydride (NCA)-derived synthetic polypeptides for nucleic acids delivery. Adv Drug Deliv Rev 2021, 171, 139–163.
2.Yu, C.; Li, L.; Hu, P.; Yang, Y.; Wei, W.; Deng, X.; Wang, L.; Tay, F. R.; Ma, J., Recent Advances in Stimulus‐Responsive Nanocarriers for Gene Therapy. Advanced Science 2021.
3.Salamanca-Buentello, F.; Daar, A. S., Nanotechnology, equity and global health. Nat Nanotechnol 2021, 16 (4), 358–361.
4.Picanco-Castro, V.; Pereira, C. G.; Covas, D. T.; Porto, G. S.; Athanassiadou, A.; Figueiredo, M. L., Emerging patent landscape for non-viral vectors used for gene therapy. Nat Biotechnol 2020, 38 (2), 151–157.
5.Kumar, R.; Santa Chalarca, C. F.; Bockman, M. R.; Bruggen, C. V.; Grimme, C. J.; Dalal, R. J.; Hanson, M. G.; Hexum, J. K.; Reineke, T. M., Polymeric Delivery of Therapeutic Nucleic Acids. Chem Rev 2021.
6.Shi, L.; Wu, W.; Duan, Y.; Xu, L.; Xu, Y.; Hou, L.; Meng, X.; Zhu, X.; Liu, B., Light-Induced Self-Escape of Spherical Nucleic Acid from Endo/Lysosome for Efficient Non-Cationic Gene Delivery. Angew Chem Int Ed Engl 2020, 59 (43), 19168–19174.
7.Chen, J.; Wang, K.; Wu, J.; Tian, H.; Chen, X., Polycations for Gene Delivery: Dilemmas and Solutions. Bioconjug Chem 2019, 30 (2), 338–349.
8.Zhou, H.; Qin, F.; Chen, C., Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy. Adv Healthc Mater 2021, 10 (5), e2001277.
9.Hatfield, S. M.; Kjaergaard, J.; Lukashev, D.; Schreiber, T. H.; Belikoff, B.; Abbott, R.; Sethumadhavan, S.; Philbrook, P.; Ko, K.; Cannici, R.; Thayer, M.; Rodig, S.; Kutok, J. L.; Jackson, E. K.; Karger, B.; Podack, E. R.; Ohta, A.; Sitkovsky, M. V., Immunological mechanisms of the antitumor effects of supplemental oxygenation. 2015, 7 (277), 277ra30–277ra30.
10.Schito, L.; Rey, S., Cell-Autonomous Metabolic Reprogramming in Hypoxia. Trends Cell Biol 2018, 28 (2), 128–142.
11.Lee, P.; Chandel, N. S.; Simon, M. C., Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol 2020, 21 (5), 268–283.
12.Telarovic, I.; Wenger, R. H.; Pruschy, M., Interfering with Tumor Hypoxia for Radiotherapy Optimization. J Exp Clin Cancer Res 2021, 40 (1), 197.
13.Li, Y.; Ding, J.; Xu, X.; Shi, R.; Saw, P. E.; Wang, J.; Chung, S.; Li, W.; Aljaeid, B. M.; Lee, R. J.; Tao, W.; Teng, L.; Farokhzad, O. C.; Shi, J., Dual Hypoxia-Targeting RNAi Nanomedicine for Precision Cancer Therapy. Nano Lett 2020, 20 (7), 4857–4863.
14.Uniacke, J.; Holterman, C. E.; Lachance, G.; Franovic, A.; Jacob, M. D.; Fabian, M. R.; Payette, J.; Holcik, M.; Pause, A.; Lee, S., An oxygen-regulated switch in the protein synthesis machinery. Nature 2012, 486 (7401), 126–9.
15.Kim, H. J., Cell Fate Control by Translation: mRNA Translation Initiation as a Therapeutic Target for Cancer Development and Stem Cell Fate Control. Biomolecules 2019, 9 (11).
16.Chee, N. T.; Lohse, I.; Brothers, S. P., mRNA-to-protein translation in hypoxia. Mol Cancer 2019, 18 (1), 49.
17.Thomas, J. D.; Dias, L. M.; Johannes, G. J., Translational repression during chronic hypoxia is dependent on glucose levels. RNA 2008, 14 (4), 771–81.
18.Nakayama, K.; Kataoka, N., Regulation of Gene Expression under Hypoxic Conditions. Int J Mol Sci 2019, 20 (13).
19.Andreev, D. E.; O’Connor, P. B.; Zhdanov, A. V.; Dmitriev, R. I.; Shatsky, I. N.; Papkovsky, D. B.; Baranov, P. V., Oxygen and glucose deprivation induces widespread alterations in mRNA translation within 20 minutes. Genome Biol 2015, 16, 90.
20.Zhang, C.; Qin, W.-J.; Bai, X.-F.; Zhang, X.-Z., Nanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy. Nano Today 2020, 35.
21.Xia, D.; Hang, D.; Li, Y.; Jiang, W.; Zhu, J.; Ding, Y.; Gu, H.; Hu, Y., Au-Hemoglobin Loaded Platelet Alleviating Tumor Hypoxia and Enhancing the Radiotherapy Effect with Low-Dose X-ray. ACS Nano 2020, 14 (11), 15654–15668.
22.Liang, X.; Chen, M.; Bhattarai, P.; Hameed, S.; Dai, Z., Perfluorocarbon@Porphyrin Nanoparticles for Tumor Hypoxia Relief to Enhance Photodynamic Therapy against Liver Metastasis of Colon Cancer. ACS Nano 2020, 14 (10), 13569–13583.
23.Wang, Z.; Gong, X.; Li, J.; Wang, H.; Xu, X.; Li, Y.; Sha, X.; Zhang, Z., Oxygen-Delivering Polyfluorocarbon Nanovehicles Improve Tumor Oxygenation and Potentiate Photodynamic-Mediated Antitumor Immunity. ACS Nano 2021, 15 (3), 5405–5419.
24.You, Y.; Zhao, Z.; He, L.; Sun, Z.; Zhang, D.; Shi, C.; Cheng, Q.; Liu, Y.; Luo, L.; Chen, T., Long‐Term Oxygen Storage Nanosystem for Near‐Infrared Light‐Triggered Oxygen Supplies to Antagonize Hypoxia‐Induced Therapeutic Resistance in Nasopharyngeal Carcinoma. Advanced Functional Materials 2020, 30 (27).
25.Krafft, M. P.; Riess, J. G., Therapeutic oxygen delivery by perfluorocarbon-based colloids. Adv Colloid Interface Sci 2021, 294, 102407.
26.Jiang, M.; Qin, B.; Luo, L.; Li, X.; Shi, Y.; Zhang, J.; Luo, Z.; Zhu, C.; Guan, G.; Du, Y.; You, J., A clinically acceptable strategy for sensitizing anti-PD–1 treatment by hypoxia relief. J Control Release 2021, 335, 408–419.
27.Li, W.; Hou, W.; Guo, X.; Luo, L.; Li, Q.; Zhu, C.; Yang, J.; Zhu, J.; Du, Y.; You, J., Temperature-controlled, phase-transition ultrasound imaging-guided photothermal-chemotherapy triggered by NIR light. Theranostics 2018, 8 (11), 3059–3073.
28.Liu, Y.; Gu, W., The complexity of p53-mediated metabolic regulation in tumor suppression. Semin Cancer Biol 2021.
29.Yuan, X.; Qin, B.; Yin, H.; Shi, Y.; Jiang, M.; Luo, L.; Luo, Z.; Zhang, J.; Li, X.; Zhu, C.; Du, Y.; You, J., Virus-like Nonvirus Cationic Liposome for Efficient Gene Delivery via Endoplasmic Reticulum Pathway. ACS Cent Sci 2020, 6 (2), 174–188.
30.Qin, B.; Yuan, X.; Jiang, M.; Yin, H.; Luo, Z.; Zhang, J.; Zhu, C.; Li, X.; Shi, Y.; Luo, L.; Du, Y.; You, J., Targeting DNA to the endoplasmic reticulum efficiently enhances gene delivery and therapy. Nanoscale 2020, 12 (35), 18249–18262.
31.Jain, R. K., Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy. 2005, 307 (5706), 58–62.